Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice

Toxicology and Applied Pharmacology

Volumn 146, Issue 2, 1997, Pages 317-327

  Gupta, Sanjiv ^a   Rogers, Lynette K ^a   Taylor, Sarah K ^a   Smith, Charles V ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; GLUTAMATE AMMONIA LIGASE; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; ENZYME INHIBITION; HYPERAMMONEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER NECROSIS; LIVER TOXICITY; MALE; MOUSE; NONHUMAN;

EID: 0030808812     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8228     Document Type: Article

References (49)

1. Bartolone J. B., Birge R. B., Sparks K., Cohen S. D., Khairallah E. A. Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. Biochem. Pharmacol. 37:1988;4763-4774.
2. Birge R. B., Bartolone J. B., Nishanian E. V., Bruno M. K., Mangold J. B., Cohen S. D., Khairallah E. A. Dissociation of covalent binding from the oxidative effects of acetaminophen. Studies using dimethylated acetaminophen derivatives. Biochem. Pharmacol. 37:1988;3383-3393.
3. Birge R. B., Bartolone J. B., Cohen S. D., Khairallah E. A., Smolin L. A. A comparison of proteins S-thiolated by glutathione to those arylated by acetaminophen. Biochem. Pharmacol. 42:1991;S197-S207.
4. Black M. Acetaminophen hepatotoxicity. Annu. Rev. Med. 35:1984;577-593.
5. 6. Carcinogenesis. 7:1986;879-883.
6. Bulera S. J., Birge R. B., Cohen S. D., Khairallah E. A. Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase. Toxicol. Appl. Pharmacol. 134:1995;313-320.
7. Corcoran G. B., Racz W. J., Smith C. V., Mitchell J. R. Effects ofN. J. Pharmacol. Exp. Ther. 232:1985;864-872.
8. Dahlin D. C., Miwa G. T., Lu A. Y. H., Nelson S. D. Np. Proc. Natl. Acad. Sci. USA. 81:1984;1327-1331.
9. Davis M. R., Kassahun K., Johnheim C. M., Brandt K. M., Baillie T. A. Glutathione andNN,N′Nin vitro. Chem. Res. Toxicol. 6:1993;376-383.
10. Fahien L. A., Cohen P. P. A kinetic study of carbamyl phosphate synthetase. J. Biol. Chem. 239:1964;1925-1934.
11. Farber J. L., Leonard T. B., Kyle M. E., Nakae D., Serroni A., Rogers S. A. Peroxidation-dependent and peroxidation-independent mechanisms by which acetaminophen kills cultured rat hepatocytes. Arch. Biochem. Biophys. 267:1988;640-650.
12. Frischer H., Ahmad T. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU [1,3-bis(chloroethyl)-1-nitrosourea]. J. Lab. Clin. Med. 89:1977;1080-1091.
13. Gaasbeek Janzen J. W., Moorman A. F. M., Lamers W. H., Charles R. Development of the heterogeneous distribution of carbamoyl-phosphate synthetase (ammonia) in rat-liver parenchyma during postnatal development. J. Histochem. Cytochem. 33:1985;1205-1211.
14. Gebhardt R., Mecke D. Heterogenous distribution of glutamine synthetase among rat liver parenchymal cellsin situ. EMBO J. 2:1983;567-570.
15. Gebhardt R., Reichen J. Changes in distribution and activity of glutamine synthetase in carbon tetrachloride-induced cirrhosis in the rat: Potential role in hyperammonemia. Hepatology. 20:1994;684-691.
16. Gerson R. J., Casini A., Gilfor D., Serroni A., Farber J. L. Oxygen-mediated cell injury in the killing of cultured hepatocytes by acetaminophen. Biochem. Biophys. Res. Commun. 126:1985;1129-1137.
17. Gilbert H. F. Molecular and cellular aspects of thiol-disulfide exchange. Adv. Enzymol. 63:1990;69-172.
18. Halmes N. C., Hinson J. A., Martin B. M., Pumford N. R. Glutamate dehydrogenase covalently binds to a reactive metabolite of acetaminophen. Chem. Res. Toxicol. 9:1996;541-546.
19. Haraguchi Y., Uchino T., Takiguchi M., Endo F., Mori M., Matsuda I. Cloning and sequence of a cDNA encoding human carbamyl phosphate synthetase I: Molecular analysis of hyperammonemia. Gene. 107:1991;335-340.
20. Haussinger D. Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular cycle during ureogenesis in perfused rat liver. Eur. J. Biochem. 133:1983;269-275.
21. Hinson J. A., Pumford N. R., Roberts D. W. Mechanisms of acetaminophen toxicity: Immunochemical detection of drug-protein adducts. Drug Metab. Rev. 27:1995;73-92.
22. Hoffmann K.-J., Streeter A. J., Axworthy D. B., Baillie T. A. Identification of the major covalent adduct formedin vitroin vivo. Mol. Pharmacol. 27:1985;566-573.
23. Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: The protective effect of allopurinol. J. Pharmacol. Exp. Ther. 255:1990;935-941.
24. Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. II. Role of covalent bindingin vivo. J. Pharmacol. Exp. Ther. 187:1973;195-202.
25. Kingdon H. S., Hubbard J. S., Stadtman E. R. Regulation of glutamine synthetase. XI. The nature and implications of a lag phase in theEscherichia coli. Biochemistry. 7:1968;2136-2142.
26. Kyle M. E., Nakae D., Serroni A., Farber J. L. 1,3-(2-Chloroethyl)-1-nitrosourea potentiates the toxicity of acetaminophen both in the phenobarbital-induced rat and in hepatocytes cultured from such animals. Mol. Pharmacol. 34:1988;584-589.
27. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. Lemoine A., Lucas C., Ings R. M. J. Metabolism of the chloroethylnitrosoureas. Xenobiotica. 21:1991;775-791.
29. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187:1973a;185-194.
31. Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187:1973b;211-217.
32. 2+. J. Biol. Chem. 260:1985;13035-13040.
33. Mori M., Morita T., Ikeda F., Amaya Y., Tatibana M., Cohen P. P. Synthesis, intracellular transport, and processing of the precursors for mitochondrial ornithine transcarbamylase and carbamoyl-phosphate synthetase-I in isolated hepatocytes. Proc. Natl. Acad. Sci. USA. 78:1981a;6056-6060.
34. Mori M., Miura S., Tatibana M., Cohen P. P. Cell-free translation of carbamyl phosphate synthetase I and ornithine transcarbamylase messenger RNAs of rat liver. Effects of dietary proteins and fasting on translatable mRNA levels. J. Biol. Chem. 256:1981b;4127-4132.
35. Nakae D., Oakes J. W., Farber J. L. Potentiation in the intact rat of the hepatotoxicity of acetaminophen by 1,3-bis(2-chloroethyl)-1-nitrosourea. Arch. Biochem. Biophys. 267:1988;651-659.
36. Nelson S. D., Pearson P. G. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol. 30:1990;169-195.
37. Nicotera P., Hinds T. R., Nelson S. D., Vincenzi F. F. Differential effects of arylating and oxidizing analogs ofNp. Arch. Biochem. Biophys. 283:1990;200-205.
38. M. J. Norusis, 1993, SPSS for Windows, SPSS Inc. Chicago.
39. Nyunoya H., Broglie K. E., Widgren E. E., Lusty C. J. Characterization and derivatization of the gene coding for mitochondrial carbamyl phosphate synthetase I of rat. J. Biol. Chem. 260:1985;9346-9356.
40. Pumford N. R., Martin B. M., Hinson J. A. A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochem. Biophys. Res. Commun. 182:1992;1348-1355.
41. Roberts D. W., Bucci T. J., Benson R. W., Warbritton A. R., McRae T. A., Pumford N. R., Hinson J. A. Immunohistochemical localization and quantitation of the 3-(cystein-S. Am. J. Pathol. 138:1991;359-371.
42. Smith C. V., Lauterburg B. H., Mitchell J. R. Covalent binding and acute lethal injury in vivo: How has the hypothesis survived a decade of critical examination? Drug Metabolism and Disposition: Considerations in Clinical Pharmacology. 1985a;MTP Press, London. p. 161-181.
43. Smith C. V., Hughes H., Lauterburg B. H., Mitchell J. R. Oxidant stress and hepatic necrosis in rats treated with diquat. J. Pharmacol. Exp. Ther. 235:1985b;172-177.
44. Smith C. V., Jaeschke H. Effect of acetaminophen on hepatic content and biliary efflux of glutathione disulfide in mice. Chem. Biol. Interact. 70:1989;241-248.
45. Smith C. V., Mitchell J. R. Acetaminophen hepatotoxicityin vivo. Biochem. Biophys. Res. Commun. 133:1985;329-336.
46. Tirmenstein M. A., Nelson S. D. Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides. J. Biol. Chem. 265:1990;3059-3065.
47. Weis M., Morgenstern R., Cotgreave I. A., Nelson S. D., Moldeus P. Np. Biochem. Pharmacol. 43:1992;1493-1505.
48. Wendel A., Feuerstein S., Konz K.-H. Acute paracetamol intoxication of starved mice leads to lipid peroxidationin vivo. Biochem. Pharmacol. 28:1979;2051-2055.
49. Zar J. H. Biostatistical Analysis. 1984;Prentice-Hall, Englewood Cliffs.